Regencell Bioscience Holdings Ltd (RGC)
4.64
+0.93
(+25.07%)
USD |
NASDAQ |
Apr 17, 16:00
4.64
0.00 (0.00%)
After-Hours: 20:00
Regencell Bioscience Holdings Price: 4.64 for April 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 16, 2024 | 3.71 | 3.71 | 3.71 | 3.71 | 0.000 |
Apr 15, 2024 | 3.85 | 4.049 | 3.70 | 3.71 | 2857.00 |
Apr 12, 2024 | 3.55 | 4.17 | 3.54 | 3.81 | 1411.00 |
Apr 11, 2024 | 3.55 | 3.80 | 3.55 | 3.80 | 462.00 |
Apr 10, 2024 | 3.81 | 3.81 | 3.67 | 3.67 | 1442.00 |
Apr 09, 2024 | 3.62 | 3.88 | 3.55 | 3.79 | 13798.00 |
Apr 08, 2024 | 3.900 | 3.900 | 3.900 | 3.900 | 0.000 |
Apr 05, 2024 | 3.90 | 3.90 | 3.70 | 3.900 | 2102.00 |
Apr 04, 2024 | 4.000 | 4.000 | 3.54 | 3.72 | 7167.00 |
Apr 03, 2024 | 4.25 | 4.25 | 3.60 | 3.865 | 2879.00 |
Apr 02, 2024 | 4.19 | 4.39 | 3.92 | 4.00 | 4164.00 |
Apr 01, 2024 | 3.82 | 4.200 | 3.82 | 3.90 | 4738.00 |
Mar 28, 2024 | 3.62 | 4.995 | 3.167 | 4.50 | 56304.00 |
Mar 27, 2024 | 3.76 | 3.76 | 3.47 | 3.47 | 776.00 |
Mar 26, 2024 | 4.48 | 4.48 | 3.16 | 3.45 | 10248.00 |
Mar 25, 2024 | 3.50 | 3.81 | 3.360 | 3.70 | 4828.00 |
Mar 22, 2024 | 3.69 | 3.69 | 3.50 | 3.50 | 1156.00 |
Mar 21, 2024 | 4.110 | 4.110 | 3.84 | 3.84 | 2317.00 |
Mar 20, 2024 | 4.14 | 4.14 | 3.99 | 3.99 | 1564.00 |
Mar 19, 2024 | 4.07 | 4.200 | 3.647 | 4.05 | 9736.00 |
Mar 18, 2024 | 4.56 | 4.56 | 4.50 | 4.50 | 1722.00 |
Mar 15, 2024 | 4.62 | 4.65 | 4.50 | 4.625 | 2585.00 |
Mar 14, 2024 | 5.26 | 5.355 | 4.822 | 4.89 | 6746.00 |
Mar 13, 2024 | 5.60 | 6.63 | 5.500 | 5.61 | 32204.00 |
Mar 12, 2024 | 4.50 | 4.50 | 4.50 | 4.50 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.45
Minimum
Mar 26 2024
46.33
Maximum
Aug 25 2021
22.81
Average
24.80
Median
May 18 2022
Price Benchmarks
Global Pharmatech Inc | 0.15 |
NovaBay Pharmaceuticals Inc | 0.0821 |
Palatin Technologies Inc | 1.89 |
iBio Inc | 1.885 |
Theriva Biologics Inc | 0.4204 |
Price Related Metrics
Market Cap | 60.38M |